Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2

Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang ZP, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, et al. (2000)
JOURNAL OF BIOLOGICAL CHEMISTRY 275(52): 41415-41423.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Abstract / Bemerkung
The membrane-type 1 matrix metalloproteinase (MT1-MMP) has been shown to be a key enzyme in tumor angiogenesis and metastasis. MT1-MMP hydrolyzes a variety of extracellular matrix components and is a physiological activator of pro-MMP-2, another MMP involved in malignancy. Pro-MMP-2 activation by MT1-MMP involves the formation of an MT1-MMP tissue inhibitors of metalloproteinases 2 (TIMP-2) pro-MMP-2 complex on the cell surface that promotes the hydrolysis of pro-MMP-2 by a neighboring TIMP-2-free MT1-MMP. The MT1-MMP TIMP-2 complex also serves to reduce the intermolecular autocatalytic turnover of MT1-MMP, resulting in accumulation of active MT1-MMP (57 kDa) on the cell surface. Evidence shown here in Timp2-null cells demonstrates that pro-MMP-2 activation by MT1-MMP requires TIMP-2. In contrast, a C-terminally deleted TIMP-2 (Delta -TIMP-2), unable to form ternary complex, had no effect, However, Delta -TIMP-2 and certain synthetic MMP inhibitors, which inhibit MT1-MMP autocatalysis, can act synergistically with TIMP-2 in the promotion of pro-MMP-2 activation by MT1-MMP. In contrast, TIMP-4, an efficient MT1-MMP inhibitor, had no synergistic effect, These studies suggest that under certain conditions the pericellular activity of MT1-MMP in the presence of TIMP-2 can be modulated by synthetic and natural (TIMP-4) MMP inhibitors.
Erscheinungsjahr
Zeitschriftentitel
JOURNAL OF BIOLOGICAL CHEMISTRY
Band
275
Ausgabe
52
Seite(n)
41415-41423
ISSN
eISSN
PUB-ID

Zitieren

Toth M, Bernardo MM, Gervasi DC, et al. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. JOURNAL OF BIOLOGICAL CHEMISTRY. 2000;275(52):41415-41423.
Toth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z. P., Bigg, H. F., Overall, C. M., et al. (2000). Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(52), 41415-41423. doi:10.1074/jbc.M006871200
Toth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z. P., Bigg, H. F., Overall, C. M., DeClerck, Y. A., Tschesche, H., Cher, M. L., et al. (2000). Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. JOURNAL OF BIOLOGICAL CHEMISTRY 275, 41415-41423.
Toth, M., et al., 2000. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(52), p 41415-41423.
M. Toth, et al., “Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, 2000, pp. 41415-41423.
Toth, M., Bernardo, M.M., Gervasi, D.C., Soloway, P.D., Wang, Z.P., Bigg, H.F., Overall, C.M., DeClerck, Y.A., Tschesche, H., Cher, M.L., Brown, S., Mobashery, S., Fridman, R.: Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. JOURNAL OF BIOLOGICAL CHEMISTRY. 275, 41415-41423 (2000).
Toth, M, Bernardo, MM, Gervasi, DC, Soloway, PD, Wang, ZP, Bigg, HF, Overall, CM, DeClerck, YA, Tschesche, Harald, Cher, ML, Brown, S, Mobashery, S, and Fridman, R. “Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2”. JOURNAL OF BIOLOGICAL CHEMISTRY 275.52 (2000): 41415-41423.

69 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

XCL1-XCR1 pathway promotes trophoblast invasion at maternal-fetal interface by inducing MMP-2/MMP-9 activity.
Zhang SM, Tian FJ, Zeng WH, Ma XL, Ren JB, Lin Y., Am J Reprod Immunol 80(3), 2018
PMID: 29856101
Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines.
Suzuki Y, Fujioka K, Ikeda K, Murayama Y, Manome Y., J Clin Neurosci 41(), 2017
PMID: 28408249
Expression and Activity of Metalloproteinases in Depression.
Bobińska K, Szemraj J, Czarny P, Gałecki P., Med Sci Monit 22(), 2016
PMID: 27098106
Lipid-soluble ginseng extract inhibits invasion and metastasis of B16F10 melanoma cells.
Yun J, Kim BG, Kang JS, Park SK, Lee K, Hyun DH, Kim HM, In MJ, Kim DC., J Med Food 18(1), 2015
PMID: 25354136
Low-dose UVB irradiation prevents MMP2-induced skin hyperplasia by inhibiting inflammation and ROS.
Dang L, Wang Y, Xue Y, He L, Li Y, Xiong J., Oncol Rep 34(3), 2015
PMID: 26133107
siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I.
Aoki M, Miyake K, Ogawa R, Dohi T, Akaishi S, Hyakusoku H, Shimada T., J Invest Dermatol 134(3), 2014
PMID: 24042342
The emerging role of MMP14 in brain tumorigenesis and future therapeutics.
Ulasov I, Yi R, Guo D, Sarvaiya P, Cobbs C., Biochim Biophys Acta 1846(1), 2014
PMID: 24657728
EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.
Ellina MI, Bouris P, Aletras AJ, Theocharis AD, Kletsas D, Karamanos NK., Biochim Biophys Acta 1840(8), 2014
PMID: 24792576
The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms.
Sinno M, Biagioni S, Ajmone-Cat MA, Pafumi I, Caramanica P, Medda V, Tonti G, Minghetti L, Mannello F, Cacci E., Stem Cells Dev 22(3), 2013
PMID: 23098139
Microfabricated collagen tracks facilitate single cell metastatic invasion in 3D.
Kraning-Rush CM, Carey SP, Lampi MC, Reinhart-King CA., Integr Biol (Camb) 5(3), 2013
PMID: 23388698
VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy.
Rodrigues M, Xin X, Jee K, Babapoor-Farrokhran S, Kashiwabuchi F, Ma T, Bhutto I, Hassan SJ, Daoud Y, Baranano D, Solomon S, Lutty G, Semenza GL, Montaner S, Sodhi A., Diabetes 62(11), 2013
PMID: 23884892
Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.
Hadass O, Tomlinson BN, Gooyit M, Chen S, Purdy JJ, Walker JM, Zhang C, Giritharan AB, Purnell W, Robinson CR, Shin D, Schroeder VA, Suckow MA, Simonyi A, Sun GY, Mobashery S, Cui J, Chang M, Gu Z., PLoS One 8(10), 2013
PMID: 24194849
Vascular protective role of vitexicarpin isolated from Vitex rotundifolia in human umbilical vein endothelial cells.
Lee SM, Lee YJ, Kim YC, Kim JS, Kang DG, Lee HS., Inflammation 35(2), 2012
PMID: 21614554
Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells.
Baldassarre M, Razinia Z, Brahme NN, Buccione R, Calderwood DA., J Cell Sci 125(pt 16), 2012
PMID: 22595522
Control and inhibition analysis of complex formation processes.
Saitou T, Itano K, Hoshino D, Koshikawa N, Seiki M, Ichikawa K, Suzuki T., Theor Biol Med Model 9(), 2012
PMID: 22863329
Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells.
Benson HL, Mobashery S, Chang M, Kheradmand F, Hong JS, Smith GN, Shilling RA, Wilkes DS., Am J Respir Cell Mol Biol 44(5), 2011
PMID: 20639459
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
Gialeli C, Theocharis AD, Karamanos NK., FEBS J 278(1), 2011
PMID: 21087457
Sulfonate-containing thiiranes as selective gelatinase inhibitors.
Testero SA, Lee M, Staran RT, Espahbodi M, Llarrull LI, Toth M, Mobashery S, Chang M., ACS Med Chem Lett 2(2), 2011
PMID: 24900296
Looking at the proteases from a simple perspective.
Castro HC, Abreu PA, Abreu PA, Geraldo RB, Martins RC, dos Santos R, Loureiro NI, Cabral LM, Rodrigues CR., J Mol Recognit 24(2), 2011
PMID: 21360607
Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.
Zhang H, Chang M, Hansen CN, Basso DM, Noble-Haeusslein LJ., Neurotherapeutics 8(2), 2011
PMID: 21455784
Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway.
Wisniewski P, Ellert-Miklaszewska A, Kwiatkowska A, Kaminska B., Cell Signal 22(2), 2010
PMID: 19788921
Protective role of betulinic acid on TNF-alpha-induced cell adhesion molecules in vascular endothelial cells.
Yoon JJ, Lee YJ, Kim JS, Kang DG, Lee HS., Biochem Biophys Res Commun 391(1), 2010
PMID: 19896462
The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.
Cho JA, Osenkowski P, Zhao H, Kim S, Toth M, Cole K, Aboukameel A, Saliganan A, Schuger L, Bonfil RD, Fridman R., J Biol Chem 283(25), 2008
PMID: 18413312
Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk.
Ogura S, Ohdaira T, Hozumi Y, Omoto Y, Nagai H., J Surg Oncol 96(1), 2007
PMID: 17385712
Control of matrix metalloproteinase catalytic activity.
Ra HJ, Parks WC., Matrix Biol 26(8), 2007
PMID: 17669641
Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking.
Wu YI, Munshi HG, Snipas SJ, Salvesen GS, Fridman R, Stack MS., Biochem J 407(2), 2007
PMID: 17650075
Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
Lee M, Villegas-Estrada A, Celenza G, Boggess B, Toth M, Kreitinger G, Forbes C, Fridman R, Mobashery S, Chang M., Chem Biol Drug Des 70(5), 2007
PMID: 17927722
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.
Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet M., J Neurooncol 78(3), 2006
PMID: 16636750
Membrane type-matrix metalloproteinases and tumor progression.
Sounni NE, Noel A., Biochimie 87(3-4), 2005
PMID: 15781320
Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase.
Toth M, Osenkowski P, Hesek D, Brown S, Meroueh S, Sakr W, Mobashery S, Fridman R., Biochem J 387(pt 2), 2005
PMID: 15560752
Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro.
Asher RA, Morgenstern DA, Properzi F, Nishiyama A, Levine JM, Fawcett JW., Mol Cell Neurosci 29(1), 2005
PMID: 15866049
Matrix metalloproteinase inhibitor RECK expression in canine tumors.
Takagi S, Kato Y, Asano K, Ohsaki T, Bosnakovski D, Hoshino Y, Okumura M, Kadosawa T, Fujinaga T., J Vet Med Sci 67(8), 2005
PMID: 16141662
Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, Fridman R., J Biol Chem 279(10), 2004
PMID: 14681236
Endoproteolytic activation of alpha(v) integrin by proprotein convertase PC5 is required for vascular smooth muscle cell adhesion to vitronectin and integrin-dependent signaling.
Stawowy P, Kallisch H, Veinot JP, Kilimnik A, Prichett W, Goetze S, Seidah NG, Chrétien M, Fleck E, Graf K., Circulation 109(6), 2004
PMID: 14970114
Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).
Osenkowski P, Toth M, Fridman R., J Cell Physiol 200(1), 2004
PMID: 15137052
Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P, Kallisch H, Kilimnik A, Margeta C, Seidah NG, Chrétien M, Fleck E, Graf K., Biochem Biophys Res Commun 321(3), 2004
PMID: 15358140
Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation.
Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J, Béliveau R., Stem Cells 21(3), 2003
PMID: 12743328
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).
Rosenblum G, Meroueh SO, Kleifeld O, Brown S, Singson SP, Fridman R, Mobashery S, Sagi I., J Biol Chem 278(29), 2003
PMID: 12679334
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V., Biochem J 372(pt 3), 2003
PMID: 12630911
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.
Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R., Biochem Biophys Res Commun 308(2), 2003
PMID: 12901881
Clinical implications of matrix metalloproteinases.
Mandal M, Mandal A, Das S, Chakraborti T, Sajal C., Mol Cell Biochem 252(1-2), 2003
PMID: 14577606
Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases.
Bernardo MM, Brown S, Li ZH, Fridman R, Mobashery S., J Biol Chem 277(13), 2002
PMID: 11790786
Matrix metalloproteinases in colorectal cancer.
Mysliwiec AG, Ornstein DL., Clin Colorectal Cancer 1(4), 2002
PMID: 12450419
Regulation of membrane type-matrix metalloproteinases.
Hernandez-Barrantes S, Bernardo M, Toth M, Fridman R., Semin Cancer Biol 12(2), 2002
PMID: 12027585
Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene.
Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM, Edwards DR., Biochem J 364(pt 1), 2002
PMID: 11988080
Strategies for MMP inhibition in cancer: innovations for the post-trial era.
Overall CM, López-Otín C., Nat Rev Cancer 2(9), 2002
PMID: 12209155
The proMMP-2 activation rate in patients with chronic viral liver disease.
Murawaki Y, Ikuta Y, Koda M, Okamoto K, Mimura K., Clin Chim Acta 324(1-2), 2002
PMID: 12204430
Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R., Biochem Biophys Res Commun 281(1), 2001
PMID: 11178970
Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL, VanMeter TE, Broaddus WC., J Neurooncol 53(2), 2001
PMID: 11716070

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 10998420
PubMed | Europe PMC

Suchen in

Google Scholar